Odyssean LLC’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BBIO
Odyssean LLC's BBIO Position: Q3 2026 in Review
Odyssean LLC increased its BridgeBio Pharma (BBIO) stake by 60% in Q3 2026, buying an estimated $1.9M and bringing the position to 65,463 shares worth $4.31M. The position accounts for 0.5% of the portfolio, ranked #61.
Odyssean LLC first reported a position in BBIO in Q4 2025 and has held it in 3 quarters since. 471 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.
- Odyssean LLC held 65,463 shares of BridgeBio Pharma worth $4.31M as of Q3 2026.
- Odyssean LLC bought 24,448 BridgeBio Pharma shares in Q3 2026, an estimated $1.9M.
- BridgeBio Pharma made up 0.5% of Odyssean LLC's portfolio in Q3 2026, its #61 holding.
- Odyssean LLC first reported a position in BridgeBio Pharma in Q4 2025 and has held it in 3 quarters since.
- 471 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.
Based on Odyssean LLC's 13F filing for Q3 2026, filed 16 Nov 2026.